蛋白尿性慢性肾脏病与红细胞寿命、变形性及代谢改变相关
该研究在小鼠蛋白尿性慢性肾脏病模型中发现贫血在造模后第10天出现、第30天进展,尽管循环促红细胞生成素水平和骨髓、脾脏红细胞生成增加;循环红细胞形态改变、渗透敏感性变形能力下降、磷脂酰丝氨酸外化增加,且回输后提前清除;代谢组学显示氧化还原循环通路和Lands循环随时间变化;蛋白尿性肾病患者循环磷脂酰丝氨酸阳性红细胞比例增加。
要点
- 蛋白尿性慢性肾脏病贫血伴随红细胞寿命缩短、变形性下降和细胞死亡增加
- 贫血发生不依赖于促红细胞生成素不足,因循环促红细胞生成素水平和红系生成增加
- 红细胞代谢改变涉及氧化还原循环通路和Lands循环膜脂重塑
核心结论
- 蛋白尿性慢性肾脏病中红细胞寿命缩短、代谢改变、变形性下降和细胞死亡增加共同促进贫血发生。
研究设计与样本
- 研究采用两种小鼠蛋白尿性慢性肾脏病模型:多柔比星给药和诱导性podocin缺陷。
主要发现
- 两种模型贫血在造模后第10天出现、第30天进展,尽管循环促红细胞生成素水平和骨髓、脾脏红细胞生成增加。
- 循环红细胞形态改变、渗透敏感性变形能力下降、磷脂酰丝氨酸外化增加,后者为红细胞死亡标志。
- 多柔比星诱导肾病小鼠第20天荧光标记红细胞显示从循环中提前清除。
- 两种模型红细胞代谢组学显示氧化还原循环通路和Lands循环随时间变化。
- 蛋白尿性肾病患者循环磷脂酰丝氨酸阳性红细胞比例增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Anemia is a common complication of chronic kidney disease, affecting the quality of life of patients. Among various factors, such as iron and erythropoietin deficiency, reduced red blood cell (RBC) lifespan has been implicated in the pathogenesis of anemia. However, mechanistic data on in vivo RBC dysfunction in kidney disease are lacking. Herein, we describe the development of chronic kidney disease-associated anemia in mice with proteinuric kidney disease resulting from either administration of doxorubicin or an inducible podocin deficiency. In both experimental models, anemia manifested at day 10 and progressed at day 30 despite increased circulating erythropoietin levels and erythropoiesis in the bone marrow and spleen. Circulating RBCs in both mouse models displayed altered morphology and diminished osmotic-sensitive deformability together with increased phosphatidylserine externalization on the outer plasma membrane, a hallmark of RBC death. Fluorescence-labelling of RBCs at day 20 of mice with doxorubicin-induced kidney disease revealed premature clearance from the circulation. Metabolomic analyses of RBCs from both mouse models demonstrated temporal changes in redox recycling pathways and Lands' cycle, a membrane lipid remodeling process. Anemic patients with proteinuric kidney disease had an increased proportion of circulating phosphatidylserine-positive RBCs. Thus, our observations suggest that reduced RBC lifespan, mediated by altered RBC metabolism, reduced RBC deformability, and enhanced cell death contribute to the development of anemia in proteinuric kidney disease.
引用
- Bissinger R, Nemkov T, D'Alessandro A, et al. Proteinuric chronic kidney disease is associated with altered red blood cell lifespan, deformability and metabolism. Kidney Int. 2021. PMID: 34537228. doi:10.1016/j.kint.2021.08.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。